Synthalab is a wholesale distributor of exosomes and is positioning itself in the regenerative therapies marketplace with a mission for humans to have the capability to repair themselves at a cellular level. The company believes that the future of regenerative therapies lie within a crossroad of AI, Biopharma, and blockchain.
Furthermore, the goal is to advance the field of regenerative medicine by providing cutting-edge exosome therapies that empower healthcare providers to optimize patient outcomes. By delivering the highest quality exosome products, we aim to support innovative treatments that promote cellular repair, regeneration, and overall well-being. Through a commitment to excellence, education, and collaboration, we strive to be a trusted partner in transforming the landscape of regenerative medicine
Company Details
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.synthalab.com
- Competitors
- Princeton Orthopaedic Associates, P.A..
Synthalab,llc Questions
Synthalab,Llc's website is https://www.synthalab.com
Synthalab,Llc's LinkedIn profile is https://www.linkedin.com/company/synthalab-llc
Synthalab,Llc's industry is
Biotechnology Research
Synthalab,Llc's top competitors are
Princeton Orthopaedic Associates, P.a..
Synthalab,Llc's categories are Biotechnology Research
Synthalab,Llc's founding year is 2025
